AKTS
Aktis Oncology, Inc.- Last price
- $22.39
- As of
Share the AKTS intelligence card
See AKTS live in the terminal
Track AKTS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live AKTS terminal, freeActive signals for AKTS
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in AKTS
- mediumNEW_POSITION
SOROS FUND MANAGEMENT LLC new position in AKTS
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 71.2% - EPS $-0.299 vs $-1.0386 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 11.5% - EPS $-0.38 vs $-0.3407 estimate
Top institutional holders of AKTS (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| SOROS FUND MANAGEMENT LLC | $1.8M | 0.02% | , |
| D. E. Shaw & Co., Inc. | $305K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, AKTS
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more AKTS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to AKTSand get the insider, 13F, options, and confluence read in one view.